Expertise in
32
conditions

Dr. Zhentao Zhang

Hematology
Parkview Packnett Family Cancer Institute
11050 Parkview Circle Dr, 
Fort Wayne, IN 
Expertise in
32
conditions
Parkview Packnett Family Cancer Institute
11050 Parkview Circle Dr, 
Fort Wayne, IN 

Overview

Zhentao Zhang is a Hematologist in Fort Wayne, Indiana. Dr. Zhang is highly rated in 32 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, and Non-Muscle Invasive Bladder Cancer.

His clinical research consists of co-authoring 22 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology

Licenses

Internal Medicine in TX

Hospital Affiliations

Dukes Memorial Hospital
Cameron Memorial Community Hospital Inc
Adams Memorial Hospital
Lutheran Hospital Of Indiana
Parkview Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Parkview Packnett Family Cancer Institute
11050 Parkview Circle Dr, Fort Wayne, IN 46845
Other Locations
Fort Wayne Medical Oncology and Hematology Inc
2514 E DuPont Rd Ste 100, Fort Wayne, IN 46825

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Multicenter Phase II Trial of Paclitaxel With and Without Nivolumab in Taxane Naive, and Nivolumab and Cabozantinib in Taxane Pretreated Subjects With Angiosarcoma
A Multicenter Phase II Trial of Paclitaxel With and Without Nivolumab in Taxane Naive, and Nivolumab and Cabozantinib in Taxane Pretreated Subjects With Angiosarcoma
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib-S-Malate, Nivolumab, Paclitaxel
Study Phase: Phase 2
Cabazitaxel With Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial
Cabazitaxel With Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2026
Intervention Type: Drug
Study Drugs: Abiraterone acetate, Antiandrogen therapy, Cabazitaxel, Prednisone
Study Phase: Phase 2
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: January 14, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Nivolumab
Study Phase: Phase 3
Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma
Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing CB-839 in Combination With Everolimus (CBE) vs. Placebo With Everolimus (PboE) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing CB-839 in Combination With Everolimus (CBE) vs. Placebo With Everolimus (PboE) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
Enrollment Status: Completed
Publish Date: September 15, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

22 Total Publications

Increased CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress that Suppresses Gene Programs for Remodeling and Enables Rescue by Gene Transfer.
Increased CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress that Suppresses Gene Programs for Remodeling and Enables Rescue by Gene Transfer.
Journal: Circulation research
Published: December 04, 2025
Similar Doctors
Expertise in
55
conditions
Dr. Sunil Babu
Hematology
Expertise in
55
conditions
Dr. Sunil Babu
Hematology

American Oncology Partners P.A.

7910 W Jefferson Blvd Ste 108, 
Fort Wayne, IN 
 (11.7 miles away)
260-484-8830
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sunil Babu is a Hematologist in Fort Wayne, Indiana. Dr. Babu is highly rated in 55 conditions, according to our data. His top areas of expertise are Thrombocytopenia, Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, and Bone Marrow Aspiration.

Expertise in
9
conditions
Dr. Sarah Wang
Hematology
Expertise in
9
conditions
Dr. Sarah Wang
Hematology

Parkview Packnett Family Cancer Institute

11050 Parkview Circle Dr, 
Fort Wayne, IN 
 (0.1 miles away)
833-724-8326
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sarah Wang is a Hematologist in Fort Wayne, Indiana. Dr. Wang is highly rated in 9 conditions, according to our data. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).

Expertise in
53
conditions
Dr. David Zimmerman
Hematology
Expertise in
53
conditions
Dr. David Zimmerman
Hematology

Office

2514 E DuPont Rd Ste 100, 
Fort Wayne, IN 
 (0.8 miles away)
260-484-8830
Languages Spoken:
English
See accepted insurances

David Zimmerman is a Hematologist in Fort Wayne, Indiana. Dr. Zimmerman is highly rated in 53 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Thrombocytopenia, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Zhentao Zhang

How do I make an appointment with Dr. Zhentao Zhang?

You can book an appointment with Dr. Zhentao Zhang by calling their office at 833-724-8326. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Zhentao Zhang a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Zhentao Zhang is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Zhentao Zhang specialize in?

While Dr. Zhentao Zhang is a Hematology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Adult Soft Tissue Sarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Zhentao Zhang participate in research or clinical trials?

Yes. Dr. Zhentao Zhang has published 22 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Zhentao Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Zhentao Zhang accept my insurance?

Dr. Zhentao Zhang accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 833-724-8326 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zhang's expertise for a condition
ConditionClose
    View All 15 Distinguished Conditions
    View All 17 Advanced Conditions
    View All 68 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile